A new analysis from the Mayo Clinic may offer a way to estimate a person’s risk of developing mild cognitive impairment or dementia up to ten years before symptoms appear. Researchers built the risk calculator using data from the Mayo Clinic Study of Aging, a project that has followed thousands of adults for nearly two decades.
The analysis evaluated roughly 5,900 cognitively healthy adults using four major predictors: age, sex, the APOE ε4 gene, and brain amyloid levels measured with PET scans. With these inputs, scientists estimated each person’s ten-year and lifetime risk of developing mild cognitive impairment or dementia. The team continued tracking participants even after they left the study, using medical records, which helped avoid a common research problem: losing the people most likely to decline. Dementia occurred twice as often among participants who dropped out compared with those who stayed.
Three main findings stood out. First, brain amyloid was the most powerful predictor of future decline. Amyloid proteins build up in the brain silently for years before memory changes appear. People with higher amyloid levels had higher ten-year and lifetime risk across all ages, sexes, and genetic backgrounds. Among 75-year-old carriers of the APOE ε4 gene, lifetime risk of mild cognitive impairment jumped from 56 percent with low amyloid to more than 80 percent with high amyloid.
Second, women carried a higher lifetime risk than men. This matches long-standing patterns: women develop mild cognitive impairment and dementia at higher rates. Hormonal shifts, immune differences, and longer life spans likely play a role.
Third, genetics still matter. Carriers of the APOE ε4 gene had higher risk across all ages and amyloid levels. But amyloid amplified that genetic vulnerability, suggesting that genes and brain biology interact long before symptoms appear.
The researchers noted that this tool points to a future where brain health is measured and managed individually, much like cholesterol and coronary calcium scores are used to assess heart disease risk. They also emphasized that daily habits still shape long-term brain trajectory. Building cardiorespiratory fitness, supporting metabolic health, prioritizing quality sleep, eating a nutrient-rich diet, staying socially connected, and continuing to learn new things are all linked to stronger cognition and slower decline.
This study does not predict any single person’s future with certainty, but it offers a clearer map of who is at highest risk long before symptoms begin. That clarity creates opportunity for earlier choices, earlier therapies, and earlier intervention.
